William Miller, MD
Family Medicine · Spartanburg, SCNPI 1407817042
Payments from drug & device makers
Across 71 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$175
- Takeda Pharmaceuticals U.S.A., Inc.$161
- Otsuka America Pharmaceutical, Inc.$93
- Lilly USA, LLC$90
- Exact Sciences$86
- Boehringer Ingelheim$68
- plus $479 from 17 others
What the payments were for
- Food & beverage$1,151100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $161 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| Lilly USA, LLC | 6 | $90 |
| Exact Sciences | 6 | $86 |
| Boehringer Ingelheim | 5 | $68 |
| Phathom Pharmaceuticals, Inc. | 4 | $62 |
| Novo Nordisk | 4 | $58 |
| Daiichi Sankyo Inc. | 3 | $58 |
| Amgen(2 entities) | 3 | $53 |
| Bayer | 3 | $40 |
| Corcept Therapeutics | 2 | $37 |
| Abiomed | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Novartis | 1 | $18 |
| GSK | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Organon | 1 | $8 |
| Dynavax Technologies Corporation | 1 | $7 |
How this compares
$1,151 in reported general payments places this provider in the 60th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 13 | $701 |
| Cefdinir | 52 | $680 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $518 |
| Doxycycline Hyclate | 37 | $345 |
| Methylprednisolone | 39 | $274 |
| Cephalexin | 53 | $232 |
| Azithromycin | 58 | $203 |
| Ketorolac Tromethamine | 12 | $153 |
| Ciprofloxacin Hcl | 22 | $141 |
| Diclofenac Sodium | 27 | $125 |
| Ondansetron OdtOndansetron | 19 | $119 |
| Amoxicillin | 25 | $103 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $94 |
| Triamcinolone Acetonide | 24 | $91 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $86 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Spartanburg
- Latasha SelibySpartanburg$24K
- George BailesSpartanburg$22K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.